Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

National trends of endoscopic retrograde cholangiopancreatography utilization and outcomes in decompensated cirrhosis.

Surgical endoscopy·2018
Same author

Interactive effects of Magnaporthe inoculation and nitrogen doses on the plant enzyme machinery and phyllosphere microbiome of resistant and susceptible rice cultivars.

Archives of microbiology·2018
Same author

Genetic diversity of <i>Cahi DRB</i> and <i>DQB</i> genes of caprine MHC class II in Sirohi goat.

Journal of genetics·2018
Same author

Observation of tt[over ¯]H Production.

Physical review letters·2018
Same author

Adult Influenza A (H1N1) Related Encephalitis: A Case Report.

Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine·2018
Same author

Search for Heavy Neutral Leptons in Events with Three Charged Leptons in Proton-Proton Collisions at sqrt[s]=13  TeV.

Physical review letters·2018

Related Experiment Video

Updated: Jun 23, 2026

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

Multifunctional magnetic nanoparticles for targeted delivery.

Arun Kumar1, Prasanna K Jena, Sumita Behera

  • 1Division of Allergy and Immunology, Department of Internal Medicine, University of South Florida, Tampa, Florida, USA.

Nanomedicine : Nanotechnology, Biology, and Medicine
|May 19, 2009
PubMed
Summary

External magnets can effectively guide magnetic nanoparticles for targeted drug delivery in vivo, concentrating them in specific organs like the lungs, heart, and kidneys without nanoparticle functionalization.

More Related Videos

Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles
08:26

Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles

Published on: October 19, 2015

Related Experiment Videos

Last Updated: Jun 23, 2026

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles
08:26

Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles

Published on: October 19, 2015

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Pharmacology

Background:

  • Targeted drug delivery remains a significant challenge in pharmaceutical therapy, often leading to nonspecific toxicity.
  • Magnetic nanoparticles offer a promising solution for precise in vivo drug and gene delivery.
  • Functionalizing nanoparticles with targeting moieties can enhance in vitro delivery but may complicate in vivo applications.

Purpose of the Study:

  • To investigate the efficacy of external magnetic fields in directing functionalized magnetic nanoparticles to specific organs for targeted therapy.
  • To evaluate the feasibility of using non-functionalized magnetic nanoparticles for site-specific drug delivery in vivo.
  • To demonstrate the potential of magnetic nanoparticles as a versatile platform for both in vitro and in vivo targeted delivery.

Main Methods:

  • Magnetic nanoparticles were conjugated with plasmid DNA encoding enhanced green fluorescent protein (EGFP) and coated with chitosan.
  • These nanoparticles were intravenously injected into mice and guided to target organs (heart, kidneys) using external magnetic fields (25 gauss or 2kA-kA/m).
  • EGFP expression was monitored using whole-body fluorescent imaging, and nanoparticle accumulation was confirmed via transmission electron microscopy. In vitro studies utilized antibody-coupled nanoparticles.

Main Results:

  • Magnetic nanoparticles successfully accumulated in the lungs, heart, and kidneys of mice when directed by an external magnetic field.
  • Expression of EGFP was successfully visualized in these targeted organs, confirming successful delivery and biological activity.
  • In vitro experiments demonstrated successful targeting using antibody-conjugated magnetic nanoparticles.

Conclusions:

  • A simple external magnetic field is sufficient to achieve targeted delivery of magnetic nanoparticles to specific organs in vivo without requiring nanoparticle functionalization.
  • This approach offers a powerful and potentially simplified method for enhancing the efficacy and reducing the toxicity of drug and gene therapies.
  • Combining magnetic targeting with functionalized nanoparticles may offer even greater efficiency for future drug delivery applications.